Prevention of Arterial and Venous Vascular Events in Symptomatic Peripheral Arterial Disease Patients After Lower Extremity Revascularization in the VOYAGER PAD Trial: Dual Anticoagulant/Antiplatelet Prevention of Arterial and Venous Vascular Events in Symptomatic Peripheral Arterial Disease Patients After Lower Extremity Revascularization in the VOYAGER PAD Trial: Dual Anticoagulant/Antiplatelet

Prevention of Arterial and Venous Vascular Events in Symptomatic Peripheral Arterial Disease Patients After Lower Extremity Revascularization in the VOYAGER PAD Trial: Dual Anticoagulant/Antiplatelet

On Monday, July 19, 2021, Scott Darrell Berkowitz, M.D., Clinician/Scientist at CPC Clinical Research and Visiting Research Professor of Medicine at the University of Colorado School of Medicine in Aurora, Colorado, presented findings from late-breaking results of an analysis from the VOYAGER PAD trial.
Read more
ISTH Registry on Pregnancy and COVID-19 Associated Coagulopathy (COV-PREG-COAG)- First Report ISTH Registry on Pregnancy and COVID-19 Associated Coagulopathy (COV-PREG-COAG)- First Report

ISTH Registry on Pregnancy and COVID-19 Associated Coagulopathy (COV-PREG-COAG)- First Report

The ISTH Scientific and Standardization Committee for Women’s Health Issues in Thrombosis and Hemostasis developed the International Registry on Pregnancy and COVID-19 Associated Coagulopathy (COV-PREG-COAG) addressing COVID-19 associated coagulopathy (CAC) in pregnancy.
Read more
RSS
12345678